Federal health authorities have announced the withdrawal of approximately 90,000 bottles of children’s ibuprofen from store shelves after customers discovered concerning foreign materials in the liquid medication.
The Food and Drug Administration published details about the recall involving Taro Pharmaceuticals’ Children’s Ibuprofen Oral Suspension on their website. According to the company’s information, this berry-flavored liquid medicine is designed for youngsters between 2 and 11 years old.
Federal officials explained in their announcement that the recall began this month following consumer complaints about “a gel-like mass and black particles in the product.” Health regulators have classified this recall as having a “remote” likelihood of causing severe harm or adverse health effects to users.
The recalled medication was produced in India by Strides Pharma Inc., a manufacturer that creates both generic medications and non-prescription drugs for companies across the United States and internationally. According to FDA documentation, Strides Pharma initiated the product withdrawal.
As of Friday morning, representatives from both Strides Pharma and Taro Pharmaceuticals had not provided responses to media inquiries about the recall.
